年度	2022
全部作者	陈秉训
论文名称	Ping-Hsun Chen*, 2022.10, 'How a Dosage Regimen Patent for RRMS Treatment May Satisfy the Written Description Requirement—A Lesson from Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc., ' Biotechnology Law Report, Vol.41, No.5, pp.240-250.(SCIE)(*为通讯作者)
卷数	440831
发表日期	2022-10-01